Age and CEA in Colorectal Cancer
Author Information
Author(s): Gobbi P G, Valentino F, Berardi E, Tronconi C, Brugnatelli S, Luinetti O, Moratti R, Corazza G R
Primary Institution: Università di Pavia, Fondazione IRCCS Policlinico S Matteo, Pavia, Italy
Hypothesis
The study aims to verify the true prognostic factors of colorectal cancer through relative survival analysis.
Conclusion
The study confirms that age and carcinoembryonic antigen (CEA) levels are significant prognostic factors in colorectal cancer, with age showing a mild protective effect on relative survival.
Supporting Evidence
- Liver metastases, age, lymph node involvement, and depth of bowel wall involvement were independent prognosticators.
- Increasing age was unfavourably related to overall survival but mildly protective regarding relative survival.
- The prechemotherapy CEA level showed high clinical value.
Takeaway
This study looked at how age and a specific blood test (CEA) can help predict how well people with colorectal cancer will do after treatment.
Methodology
The study involved 506 patients who underwent locally radical resection, with analyses of clinical, histological, and laboratory parameters for overall and relative survival.
Potential Biases
Potential bias due to the exclusion of patients with incomplete data.
Limitations
The study is limited to patients who underwent local radical resection and may not apply to those with different treatment histories.
Participant Demographics
The mean age of participants was 64.3 years, with a majority being male (292 out of 506).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website